Enzyme inhibition protects against Huntington's disease damage in two animal models
Treatment with a novel agent that inhibits the activity of SIRT2, an enzyme that regulates many important cellular functions, reduced neurological damage, slowed the loss of motor function and extended survival in two animal models of Huntington's disease. The study led by Massachusetts General Hospital (MGH) researchers will appear in the Dec. 27 issue of Cell Reports and is receiving advance online release.
"I believe that the drug efficacy demonstrated in two distinct genetic HD mouse models is quite unique and highly encouraging," says Aleksey Kazantsev, PhD, of the MassGeneral Institute for Neurodegenerative Disorders, senior author of the study. "The outcome suggests that designing stronger SIRT2 inhibitors is a valid strategy for developing drugs to slow the progression of HD, something that currently does not exist."
Earlier studies by Kazantsev's group and others showed that inhibiting SIRT2 (sirtuin-2 deacetylase) protected against neuronal damage in cellular and animal models of HD and Parkinson's disease – both of which are characterized by the buildup of abnormal proteins in the brain – and in other neurodegenerative disorders. The current study was designed to evaluate in two mouse models of HD use of a new, brain-permeable SIRT2 inhibitor called AK-7, first identified by members of the MGH team in 2011. One model called R6/2 is characterized by robust progression and severity of neurological symptoms. The other, called 140 CAG Htt knock-in, is genetically closer to the human disease. In both models, the mutated huntingtin gene contains extended repeats of the nucleotide triplet CAG, leading to development of HD-like motor symptoms and the same type of brain damage seen in the devastating neurological disorder.
Animals from both strains received two daily injections of AK-7 at one of three dose levels – 10, 20 or 30 mg/kg – beginning at the age of 4 weeks and continuing for up to 14 weeks. Among the R6/2 animals, those treated with AK-7 retained significantly more motor function than did untreated animals and had less shrinkage of brain structures affected by HD and smaller aggregates of the mutant huntingtin protein characteristic of the disorder. Treated animals in this model, which usually die prematurely, lived 13 percent longer than untreated R6/2 mice.
In the experiments with the 140 CAG Htt knock-in model, treated animals maintained activity levels similar to those of normal mice for several months, while untreated mice showed a rapid decline in motor activity. In that model, 14 weeks of treatment reduced mutant huntingtin aggregates in the most affected area of the brain by more than 50 percent, compared with untreated animals from the same strain.
"The golden rule in the HD field for identifying compounds that could work in patients is showing efficacy in a robust HD model like R6/2 and in the more genetically accurate to human disease 140 CAG Htt knock-in model," says Kazantsev, an associate professor of Neurology at Harvard Medical School. "The next essential and critical step will be testing additional, structurally diverse SIRT2 inhibitors in HD mice, and we are preparing to test one that is 10 times more potent than AK-7. If and when that compound and others also show efficacy, that will give us definitive proof of the therapeutic potential of SIRT2 inhibition for HD."
Journal reference: Cell Reports
Provided by Massachusetts General Hospital
- Animal study identifies potential treatment for Huntington's disease Oct 08, 2007 | not rated yet | 0
- Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease Dec 18, 2011 | not rated yet | 0
- Immune cell migration is impeded in Huntington's disease Nov 19, 2012 | not rated yet | 0
- Novel mouse model provides insight into rare neurodegenerative disease May 11, 2011 | not rated yet | 0
- Transcription factor clears protein clumps in Huntington's mice models Dec 14, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
New research presented today shows that formation of new neurons in the hippocampus - a brain region known for its importance in learning and remembering - could cause forgetting of old memories by causing a reorganization ...
Neuroscience 6 hours ago | 3.7 / 5 (3) | 0
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Neuroscience 7 hours ago | 4 / 5 (2) | 2
One of the major frontiers of modern science is a comprehensive understanding of the human brain and its functions to guide the development of new technologies in information and communication. In a major announcement for ...
Neuroscience 7 hours ago | 1 / 5 (1) | 0
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Neuroscience 22 hours ago | 4.9 / 5 (9) | 0 |
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
Neuroscience May 23, 2013 | 3 / 5 (2) | 3 |
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
1 hour ago | 5 / 5 (1) | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
1 hour ago | not rated yet | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
7 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
4 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
4 hours ago | 5 / 5 (2) | 0 |
(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published ...
4 hours ago | not rated yet | 0